INTRODUCTION
Local recurrence in patients with rectal cancer remains a serious problem. The incidence after radical operation ranges from 2.6 to 32.0% and it has a very poor prognosis 1, 2 . In patients with total mesorectal excision and an achieved negative radial resection margin (circumferential resection margin) local recurrence is less than 10%. However, up to 28% of patients with total mesorectal excision have findings of a positive radial resection margin (less than 1mm). In these patients the risk of local recurrence dramatically rises (up to 38%) (ref. 3, 4 ). Due to its high risk, treatment of locally advanced rectal cancer requires an individualized approach, including optimalization of surgical technique and deciding on possible multimodal treatment. Part of this approach includes preoperative or postoperative external radiotherapy. Due to better oncological and functional results, preoperative radiotherapy is generally preferred, often in combination with concomitantly applied chemotherapy 5, 6 . Patients with a positive or very narrow radial resection margin require radiotherapy in a dose exceeding 60 Gy to achieve better local control. Administration of such a high dose of external radiotherapy exceeds the tolerated dose and carries a high risk of causing damage to surrounding organs, primarily the small intestine and the urinary bladder. A solution seems to be the combination of preoperatively administered radiotherapy in a dose of 45.0 -50.4 Gy and radical resection with application of intraoperative radiotherapy to a precisely defined area while protecting the surrounding structures 7, 8 .
MATERIAL AND METHODS

Patient sample
Patients with precisely defined indication criteria were indicated for IORT. All had histologically verified primary locally advanced adenocarcinoma of the lower rectumstage T3-4NxM0 (International Union Against Cancer, 7th edition), had no known oncological disease in their medical history, had never undergone radiotherapy to the pelvic region and were never administered chemotherapy. As part of disease staging, all patients underwent pancolonoscopy to rule out possible synchronous colorectal cancer, chest X-ray or CT, abdominal CT, and MRI of the pelvic region. Patients with a very severe comorbidity and those younger than 18 years were not indicated for this treatment. Prior to the beginning of therapy, all patients were reviewed by a multidisciplinary oncological committee and gave written consent to the planned treatment procedure.
Treatment protocol
All patients were indicated for neoadjuvant concomittant chemoradiotherapy. External radiotherapy was applied to the pelvic area in 25 fractions (5 fractions/week) totaling a dose of 45 Gy (1.8 Gy/fraction). Together with the radiotherapy, patients were administered capecitabin in a peroral dose of 825 mg/m 2 every 12 h. The surgical procedure was planned 6-8 weeks after the completion of chemoradiotherapy. The day before the surgery, all patients underwent an MRI scan of the pelvic region. Patients selected for IORT were those patients with findings of persisting T3-4 tumor (International Union Against Cancer, 7. edition), in which the MRI showed suspicion of possible infiltration to the mesorectal fascia or surrounding organs -T3cd, T4ab (ref. 9, 10 ). Patients with sphincter-preserving or multivisceral resection were not included, only patients with laparoscopically assisted abdominoperineal amputation of the rectum were selected. One port for the laparoscopic camera and three working ports were used during the resection in all patients. At the beginning of the operation, an intraoperative ultrasound of the liver was performed to rule out possible preoperatively occult synchronous metastases. The abdominoperineal amputation of the rectum with reconstruction of the perineum followed. After completing the resection and selecting a suitable tubus, the patient was transported to the radiation treatment room while continually monitoring vital functions. Via suprapubically localized minilaparotomy (Phannestiel incision), a tubus was introduced into the presacral area, which after isolation of surrounding structures was attached to the radiating head of the linear accelerator ( Fig. 1) . The dose was determined based on the completeness of the surgical resection taking into account the possibility of a positive radial resection margin. Standardly, in cases of R0 resection, a dose of 10 Gy is administered; if an R1 resection is presumed 12 Gy are administered, and if macroscopic tumor residuum remains (R2) then 15-20 Gy are administered [11] [12] [13] . Following radiation, the patient was transported back to the operating room where the surgical procedure was completed (Fig.  2) . Adjuvantly, patients were again administered 4-6 cycles of capecitabin in a dose of 825 mg/m 2 perorally every 12 h. All patients underwent follow-up visits on the 7 th and 30 th day after being released from hospital and then every 3 months where follow up examinations, as part of oncosurgical dispensarisation, took place.
Between August 31st, 2010 and November14th, 2011, a total of 212 patients with colorectal cancer were operated on at the Department of Surgery at the Hospital Nový Jičín. Eighty of these patients had tumors localized less than 12 cm from the anal verge. Of these patients, 17 with locally advanced primary adenocarcinoma of the lower rectum were selected for abdominoperineal amputation of the rectum with intraoperative radiotherapy. verge was 25 mm (15-30 mm) and the surgical procedure was performed 41 to 138 days (median 49 days) after the completion of neoadjuvant chemoradiotherapy. The operation performed 138 days after completing preoperative oncological treatment was due to postponement for personal reasons by the patient.
RESULTS
Sixteen of the 17 patients included in the study underwent laparoscopically assisted abdominoperineal amputation of the rectum. In one patient with a BMI of 34.2 kg/m 2 , the surgical procedure was converted to an open procedure during the phase of mesorectal excision. The duration of surgical procedure together with IORT was 185 to 345 min (median 285 min). The duration of IORT alone, including transportation of the patient to the radiation treatment room and back was 22 to 35 min (median 25 min). In all operated patients, the tubus used for IORT had an angle of 30°, in 16 patients the diameter was 64 mm and in one patient with a narrow pelvis a tubus with a diameter of 32 mm was used. In 14 patients the intraoperative dose administered was 10 Gy. In two patients a dose of 12 Gy was administered, in one of these patients definitive histological findings confirmed microscopic tumorous infiltration of the circumferential resection margin (<1 mm). No serious intraoperative complications were observed in any of the patients. Blood loss ranged from 30 to 500 mL (median 100 mL). Postoperative complications were observe in four patients (23.5%), of those only two required surgical reintervention (11.8%). A 59-year-old patient was re-operated on the 3 rd postoperative day for ileus of the small intestine, caused by incarceration of a loop of the terminal ileum in a small opening in the pelvic peritoneal suture line. Re-operation, however, did not require resection of the small intestine, and the defect in the suture of the peritoneum was treated by resuture. One patient presented with an abscess of the perineum and presacral space, which was treated by application of the negative pressure wound therapy system. This patient in the later postoperative course had ongoing urinary retention which required long-term derivation by urinary catheter. In one patient a small hematoma was evacuated from the incision on the perineum and in one patient a subcutaneous hematoma around the colostomy was treated conservatively. The duration of postoperative hospitalization was 6 to 35 days (median 7 days). All patients are currently followed up at our department and in a follow-up interval of 2 to 16 months (median 12 months). No local recurrence or disease generalization have been observed to date.
DISCUSSION
Intraoperative radiotherapy, as a part of multimodal therapy, improves local control in patients with locally advanced or recurrent cancer of the rectum 14, 15 . The risk of local recurrence in the area where radiotherapy was applied is lower in IORT when compared with external radiotherapy. Local control is 8% higher when using IORT (ref. 13, [16] [17] [18] [19] [20] ). Roeder and Krempien actually report up to 18% lower incidence of local recurrence in the area of applied IORT (ref. 13, 20 ). Sadahiro et al. in their study aimed at patients with advanced rectal cancer T3-4NxM0, compared achieved results between a group of 68 patients with resection alone and a group of 99 patients where radiochemotherapy was applied and subsequently resection with IORT was performed. Both groups were comparable in age, gender, tumor localization, tumor size and stage. 44% of patients with primary resection and 53% of patients with an initially multimodal approach underwent postoperative chemotherapy. Five-year overall survival was 79% in patients with combined therapy versus 58% in patients who underwent only surgical resection 12 . In our small sample of patients, no cases of local recurrence after IORT have been reported to date. However, the duration of follow-up is too short (median 12 months) for conclusions to be drawn.
Generally IORT is associated with a higher risk of perioperative complications and a serious postoperative complication rate of 30-40%. Most often these include gastrointestinal, urological and dermatological complications. We frequently encounter infectious complications associated with the surgical procedure in patients after IORT (ref. 21 ). Mathis et al. reported a significant association between radiation dose and frequency of pelvic complications. A lower incidence of these complications was noted with doses of less than 12.5 Gy (ref. 16 ). DiazGonzalez et al. presented up to 37% morbidity associated with IORT as part of multimodal therapy. The most frequent complications were surgical site infection, pain and presacral abscess 17 . Sadahiro et al. reported 23% surgical site infections in patients with IORT in comparison to 11.7% complications in patients who underwent only the surgical resection 12 . Mannaerts et al. noted 29% surgical site infections associated with IORT administration as part of a multimodal treatment of rectal cancer 22 . We found an infectious complication in the form of an abscess in the presacral space and in the perineal incision in one patient (5.9%). A possible decrease in the incidence of surgical site infections in our pilot study may be associated with the use of a minimally-invasive approach, and laparoscopic assistance during abdominoperineal amputation of the rectum.
It is often reported in the literature that IORT administration is associated with a higher risk of postoperative urological and gastrointestinal complications. Bladder malfunction is reported in 2 to 16% of cases and postoperative ureteral obstruction in up to 12% (ref. 12, 16, 20, 22, 23 ). In our set of patients, postoperative urinary retention was encountered in one patient (5.9%), which required drainage by long-term indwelling catheter. Gastrointestinal complications are reported in up to 14% of cases 16 . Another complication which may be associated with IORT application is peripheral neuropathy, which is seen in 8-19% of cases 16, 22 .
Combining laparoscopic resection of the rectum with IORT is very rare to date. Civello et al. presented a sample of six patients with locally advanced rectal cancer, who underwent neoadjuvant radiochemotherapy followed by laparoscopic resection of the rectum with IORT. The duration of the surgical procedure ranged from 280 to 360 min. There were no severe complications associated with the operation and all patients were released from hospital by the 8 th postoperative day 24 .
CONCLUSION
Intraoperative radiotherapy of primary rectal cancer as part of a multimodal therapy leads to a decrease in the incidence of local recurrence, however, with an acceptably slightly higher risk of postoperative infectious complications. Long-term follow-up of these selected patients as well as comparison of the results are therefore necessary to establish definite guidelines.
